Practical Insights on Strategic Communication in Biotech and Critical Industries

Today Jessica is joined by Jules Abraham, Principal at JQA Partners and Managing Director, Communications at CORE IR. They discuss the crucial differences in communication strategies for large-cap firms versus biotech startups and how to navigate complex regulatory milestones, particularly communicating vital FDA approvals. Jules also shares thoughts on proactive crisis management in high-stakes industries like biotech and healthcare and reveals his process for translating intricate scientific data into compelling narratives for diverse stakeholders.

 

Connect with Jules on LinkedIn: linkedin.com/jules-abraham-02045b2 

 

Follow Communicating Capital:

Instagram: @communicatingcapital

YouTube: @CommunicatingCapital

X: @CommCapPod

LinkedIn: linkedin.com/company/communicatingcapital